These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37023965)

  • 21. Non-alcoholic fatty liver disease.
    Li W; Alazawi W
    Clin Med (Lond); 2020 Sep; 20(5):509-512. PubMed ID: 32934047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease and cardiovascular risk: an update.
    Mullish BH; Forlano R; Manousou P; Mikhailidis DP
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1175-1177. PubMed ID: 30791787
    [No Abstract]   [Full Text] [Related]  

  • 23. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.
    Della Pepa G; Vetrani C; Lombardi G; Bozzetto L; Annuzzi G; Rivellese AA
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28954437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic fatty liver disease: A real threat in Pakistan.
    Abbas Z; Zaheer R
    J Pak Med Assoc; 2020 Dec; 70(12(B)):2437-2440. PubMed ID: 33475559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD).
    Brain D; O'Beirne J; Hickman IJ; Powell EE; Valery PC; Kularatna S; Tulleners R; Farrington A; Horsfall L; Barnett A
    BMC Health Serv Res; 2020 Apr; 20(1):335. PubMed ID: 32316984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.
    Sukahri S; Mohamed Shah FZ; Ismail AI; Koshy M; Johari B; Mohd Razali M; Abdul Rahman TH; Isa MR; Abdul Ghani R
    PLoS One; 2021; 16(6):e0253298. PubMed ID: 34191823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.
    Lee BW; Lee YH; Park CY; Rhee EJ; Lee WY; Kim NH; Choi KM; Park KG; Choi YK; Cha BS; Lee DH;
    Diabetes Metab J; 2020 Jun; 44(3):382-401. PubMed ID: 32431115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Blood Fatty Acid Composition and Dietary Pattern with the Risk of Non-Alcoholic Fatty Liver Disease in Patients Who Underwent Cholecystectomy.
    Shim P; Choi D; Park Y
    Ann Nutr Metab; 2017; 70(4):303-311. PubMed ID: 28595185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.
    Eshraghian A; Hamidian Jahromi A
    World J Gastroenterol; 2014 Jul; 20(25):8102-9. PubMed ID: 25009382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic Fatty Liver Disease in Children.
    Muzurović E; Polyzos SA; Mikhailidis DP; Borozan S; Novosel D; Cmiljanić O; Kadić N; Mantzoros CS
    Curr Vasc Pharmacol; 2023; 21(1):4-25. PubMed ID: 36411561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
    Bertot LC; Adams LA
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
    Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
    Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.
    ; Lonardo A; Bellentani S; Argo CK; Ballestri S; Byrne CD; Caldwell SH; Cortez-Pinto H; Grieco A; Machado MV; Miele L; Targher G
    Dig Liver Dis; 2015 Dec; 47(12):997-1006. PubMed ID: 26454786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The overall computer/mobile devices usage time is related to newly diagnosed non-alcoholic fatty liver disease: a population-based study.
    Meng G; Liu F; Fang L; Li C; Zhang Q; Liu L; Wu H; Du H; Shi H; Xia Y; Guo X; Liu X; Bao X; Su Q; Gu Y; Yu F; Yang H; Yu B; Sun S; Wang X; Zhou M; Jia Q; Guo Q; Chen X; Song K; Wang G; Huang G; Niu K
    Ann Med; 2016 Nov; 48(7):568-576. PubMed ID: 27649339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid Function and Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects.
    Liu Y; Wang W; Yu X; Qi X
    Ann Hepatol; 2018 Aug; 17(5):779-788. PubMed ID: 30145565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
    Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
    J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.
    Toshikuni N; Tsutsumi M; Arisawa T
    World J Gastroenterol; 2014 Jul; 20(26):8393-406. PubMed ID: 25024597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.
    Araújo AR; Rosso N; Bedogni G; Tiribelli C; Bellentani S
    Liver Int; 2018 Feb; 38 Suppl 1():47-51. PubMed ID: 29427488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.